hydroxychloroquine has been researched along with B16 Melanoma in 2 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wang, Y | 2 |
Zhou, Z | 1 |
Chen, W | 1 |
Qin, M | 2 |
Zhang, Z | 2 |
Gong, T | 1 |
Sun, X | 1 |
Shi, K | 1 |
Zhang, L | 1 |
Hu, G | 1 |
Wan, J | 1 |
Tang, J | 1 |
Yin, S | 1 |
Duan, J | 1 |
Wang, N | 1 |
Xie, D | 1 |
Gao, X | 1 |
Gao, H | 1 |
He, Q | 1 |
2 other studies available for hydroxychloroquine and B16 Melanoma
Article | Year |
---|---|
Potentiating bacterial cancer therapy using hydroxychloroquine liposomes.
Topics: Animals; Antineoplastic Agents; Autophagy; Bacterial Vaccines; Cell Line, Tumor; Cell Survival; Cyto | 2018 |
Significantly enhanced tumor cellular and lysosomal hydroxychloroquine delivery by smart liposomes for optimal autophagy inhibition and improved antitumor efficiency with liposomal doxorubicin.
Topics: Animals; Antineoplastic Agents; Autophagy; Biophysical Phenomena; Doxorubicin; Drug Delivery Systems | 2016 |